Sutro Biopharma Inc (STRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -105,538 | -67,413 | -36,511 | -30,359 | -32,128 |
| Depreciation Amortization | 7,625 | 5,511 | 3,605 | 1,787 | 4,787 |
| Accounts receivable | -6,895 | -6,771 | -3,601 | -1,668 | 739 |
| Accounts payable and accrued liabilities | 2,708 | 4,484 | 1,742 | -462 | -1,141 |
| Other Working Capital | -17,620 | -20,752 | -21,677 | -17,717 | -11,486 |
| Other Operating Activity | 38,041 | 24,842 | 20,749 | 17,989 | -28,573 |
| Operating Cash Flow | $-81,679 | $-60,099 | $-35,693 | $-30,430 | $-67,802 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -15,323 | -12,786 | -7,789 | -2,376 | -7,129 |
| Purchase Of Investment | -248,727 | -226,109 | -202,315 | -164,604 | -130,741 |
| Sale Of Investment | 166,726 | 120,799 | 94,250 | 45,250 | 138,385 |
| Other Investing Activity | 9 | 0 | 0 | 0 | 89 |
| Investing Cash Flow | $-97,315 | $-118,096 | $-115,854 | $-121,730 | $604 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 25,000 |
| Debt Repayment | N/A | N/A | N/A | N/A | -10,000 |
| Common Stock Issued | 2,485 | 1,972 | 1,812 | 1,360 | 1,861 |
| Common Stock Repurchased | -7 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 778 | 778 | -25 | 466 | 252,386 |
| Financing Cash Flow | $3,256 | $2,750 | $1,787 | $1,826 | $269,247 |
| Beginning Cash Position | 207,024 | 207,024 | 207,024 | 207,024 | 4,975 |
| End Cash Position | 31,286 | 31,579 | 57,264 | 56,690 | 207,024 |
| Net Cash Flow | $-175,738 | $-175,445 | $-149,760 | $-150,334 | $202,049 |
| Free Cash Flow | |||||
| Operating Cash Flow | -81,679 | -60,099 | -35,693 | -30,430 | -67,802 |
| Capital Expenditure | -15,323 | -12,786 | -7,789 | -2,376 | -7,129 |
| Free Cash Flow | -97,002 | -72,885 | -43,482 | -32,806 | -74,931 |